Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Compensation Expense

Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands):

	Year Ended December 31,
	2019		2018
Research and development	$	17	$	—
Sales and marketing	6		—
General and administrative	10		—
	$	33	$	—

Stock Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Options Granted, Exercised, Expired and Forfeited

A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the years ended December 31, 2019 and 2018 is presented below:

	Outstanding				Exercisable
	Number of Options		Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
Options outstanding, December 31, 2017	120,200		$	19.90	120,200	$	19.90
Expired	(1,000	)	22.10
Forfeited	(1,197	)	16.80
Options outstanding, December 31, 2018	118,003		19.90		118,003	19.90
Exchanged for Oblong Industries stock options	107,845		4.92
Expired	(440	)	16.48
Forfeited	(10,063	)	23.20
Options outstanding and exercisable, December 31, 2019	215,345		$	12.27	215,345	$	12.27

Shares Outstanding and Exercisable, By Exercise Price Range

Additional information as of December 31, 2019 is as follows:

	Outstanding and Exercisable
Range of price	Number of Options	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price
$0.00 – $10.00	110,345	0.81	$	5.01
$10.01 – $20.00	97,500	3.06	19.32
$20.01 – $30.00	2,500	2.44	21.80
$30.01 – $40.00	5,000	2.20	30.20
	215,345	1.88	$	12.27

Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity

A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the years ended December 31, 2019 and 2018, is presented below:

	Restricted Shares		Weighted Average Grant Price
Unvested restricted stock outstanding, December 31, 2017	34,100		$	10.60
Vested	(22,780	)	8.40
Unvested restricted stock outstanding, December 31, 2018	11,320		14.88
Vested	(1,372	)	15.72
Forfeited	(9,321	)	14.70
Unvested restricted stock outstanding, December 31, 2019	627		$	15.80

Schedule of Compensation Expense

Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands):

	Year Ended December 31,
	2019		2018
Research and development	—		1
General and administrative	3		14
	$	3	$	15

RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity

A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the years ended December 31, 2019 and 2018, is presented below:

	Restricted Stock Units		Weighted Average Grant Price
Unvested restricted stock units outstanding, December 31, 2017	175,200		$	5.70
Granted	487,800		1.70
Vested	(55,400	)	7.50
Forfeited	(104,082	)	4.30
Unvested restricted stock units outstanding, December 31, 2018	503,518		1.94
Granted	55,479		1.30
Vested	(114,505	)	3.05
Forfeited	(421,158	)	1.54
Unvested restricted stock units outstanding, December 31, 2019	23,334		$	2.20

Schedule of Compensation Expense

Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands):

	Year Ended December 31,
	2019		2018
Cost of revenue	$	10	$	43
Research and development	12		50
Sales and marketing	—		7
General and administrative	52		250
	$	74	$	350